The CDC warns against kissing or hugging pet poultry, which may carry salmonella. The illness is not life-threatening for most people, but the elderly, infants, young children and people with chronic disease or weakened immunity face higher risk.
Section archive
Government
Updates from the FDA, CDC and other agencies.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Government
FDA authorizes use of prosthesis for rehabilitation of above-the-knee amputations
The FDA authorized the OPRA device, the first prosthesis marketed in the US for adults with above-the-knee amputations who cannot use a conventional socket. Fixtures and screws implanted into the thigh bone in two surgeries, about six months apart, anchor an external limb.
Government
FDA Strengthens Warning of Heart Attack and Stroke Risk for Non-Steroidal Anti-Inflammatory Drugs
The FDA is strengthening warnings on prescription and over-the-counter NSAID labels to say the drugs can raise the chance of heart attack or stroke. Those effects can appear within the first few weeks of use and the risk may rise the longer they are taken. Aspirin is exempt.
Government
FDA Updates for Health Professionals
The FDA's roundup for clinicians collects announcements, guidances, approvals, safety notices and meetings, including its new Health Professionals site and Operation Pangea VIII, in which 115 countries took 2,400 websites offline and seized $81 million in illegal medical products.
Government
FDA Updates for Health Professionals - 050615
An FDA bulletin for health professionals summarizing early May 2015 announcements, comment opportunities, product approvals, safety items, meetings and resources, including the new AccessGUDID portal for medical device identification data.
Government
FDA Updates for Health Professional -042215
An FDA roundup for health professionals: highlights from the commissioner's keynote to the Food and Drug Law Institute on science-based decisions, an invitation to the Public Health Service's May 6 virtual Nurse Recognition Day, and a warning against the supplement Tri-Methyl Xtreme.
Government
Preventing Iran from acquiring a nuclear weapon - email from President Obama
An email from President Obama describing the framework reached with Iran: the Arak reactor core dismantled and replaced, spent fuel shipped out, installed centrifuges cut by two-thirds, and no more enrichment at Fordow.
Government
Consumers told it to the FTC: Top 10 complaints for 2014
The FTC's 2014 tally of more than 2.5 million complaints put identity theft first at 13 percent and debt collection second at 11 percent. Imposter scams reached the top three for the first time, driven by IRS and other government impostor frauds.
Government
FDA Updates for Health Professionals - 022515
An FDA roundup for health professionals covering a vacancy for Deputy Director of the Office of Generic Drugs and the agency's tentative finding that it needs more data on the sunscreen ingredients ecamsule and enzacamene under the Sunscreen Innovation Act.
Government
Approval changes to the Kaletra (lopinavir/ritonavir)
FDA approved Kaletra label changes adding pregnancy dosing: 400/100 mg twice daily for pregnant patients with no documented lopinavir resistance substitutions, no once-daily dosing in pregnancy, no postpartum adjustment, and avoiding the oral solution in pregnant women.
Government
FDA Updates for Health Professionals - 012915
An FDA bulletin lists CDER's summary of 2014 novel approvals, a final order requiring premarket approval applications for automated external defibrillators, the first clearance of mobile apps that share continuous glucose monitor data, and Robert Califf's appointment as deputy commissioner.
Government
FDA okays psoriasis treatment Cosentyx
The FDA approved Novartis's Cosentyx (secukinumab), an injected antibody that blocks the inflammatory protein IL-17A, for adults with moderate-to-severe plaque psoriasis. In four trials with 2,403 patients it cleared skin more often than placebo.
Government
FDA Updates for Health Professionals
An FDA roundup for health professionals: a Drug Info Rounds video on disposing of unused medicines, a Medscape interview on new labeling for pregnant and breastfeeding women, and open comment requests on risk disclosure in direct-to-consumer TV drug ads.
Government
From FDA: Need Relief From Overactive Bladder Symptoms?
An FDA consumer update describes overactive bladder, which affects more than 33 million Americans, and lists approved options: oral drugs, a skin patch or gel, the first over-the-counter treatment for women, and bladder injections for more severe symptoms.
Government
How to solve your post-holiday consumer problems
FTC tips for post-holiday purchase problems: contact the seller quickly, since return windows are short, then escalate to company headquarters. A written complaint should name model numbers, include copies of receipts and set a deadline; dispute resolution programs are a further step.
Government
FDA approves Viekira Pak to treat hepatitis C
The FDA approved Viekira Pak, ombitasvir, paritaprevir and ritonavir tablets packaged with dasabuvir, for chronic hepatitis C genotype 1 including patients with cirrhosis. It is the fourth hepatitis C drug the agency has cleared in a year.
Government
Drug Information Update - FDA approves new antibacterial drug Zerbaxa
The FDA approved Zerbaxa (ceftolozane/tazobactam) for complicated intra-abdominal and urinary tract infections in adults, the fourth new antibacterial cleared that year. Its Qualified Infectious Disease Product status brought priority review and five extra years of exclusivity.
Government
FDA final rule on pregnancy and lactation labeling information for prescription drug and biological products
FDA's final rule replaces the A, B, C, D and X pregnancy letter categories on prescription drug and biologic labels with three subsections: Pregnancy, Lactation, and Females and Males of Reproductive Potential. Officials say the letters were oversimplified and misread as a grading system.
223 stories